GLOBEIMMUNE INC
Tarmogen product candidates—therapeutic immunotherapies engineered to treat cancer and infectious diseases
- Sector
- Biotech
- Headquarters
- LOUISVILLE, CO
- Latest Form D
- $2.1M, Mar 2017
- Total capital
- $43.1M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $43.1M
- 6 Form D · last Mar 2017
- 115 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 13
- 26 pending · first 2014
- Rank in peer group#131 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 6th filing$2.1M
- Private capital raisedForm D · SEC · 5th filing$392K
- Private capital raisedForm D · SEC · 4th filing$7.5M
- Private capital raisedForm D · SEC · 3rd filing$17.5M
- Private capital raisedForm D · SEC · 2nd filing$13M
- Private capital raisedForm D · SEC · 1st filing$2.6M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#131 · top 9%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- David C ApelianResearcherExecutive OfficerLinked by 4 patents
- Augustine J LawlorDirectorNamed in SEC Form D filings
- C Jeffrey DekkerExecutive OfficerNamed in SEC Form D filings
- C. Jeffrey DekkerExecutive OfficerNamed in SEC Form D filings
- Charles Jeffrey KimDirectorNamed in SEC Form D filings
- Dan J MitchellDirectorNamed in SEC Form D filings
Show all 19 people
- Darren C CarrollDirectorNamed in SEC Form D filings
- Ehud GellerDirectorNamed in SEC Form D filings
- Jeff RonaExecutive OfficerNamed in SEC Form D filings
- Jerel Jeffrey BanksDirectorNamed in SEC Form D filings
- J William FreytagDirectorNamed in SEC Form D filings
- J. William FreytagDirectorNamed in SEC Form D filings
- John FrenzExecutive OfficerNamed in SEC Form D filings
- Kirk A ChristoffersenExecutive OfficerNamed in SEC Form D filings
- Paul A MieyalDirectorNamed in SEC Form D filings
- Pennina J SaferDirectorNamed in SEC Form D filings
- Ralph E ChristoffersenDirectorNamed in SEC Form D filings
- S Edward TorresDirectorNamed in SEC Form D filings
- Timothy C RodellExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 13 granted of 39- PendingLysates Of Recombinant Yeast For Inducing Cellular Immune ResponsesUSPTOApplication 18897645
- GrantedLysates Of Recombinant Yeast For Inducing Cellular Immune ResponsesUSPTOUS 12,128,078
- PendingAnti COVID-19 Therapies Using Nucleocapsid And Spike ProteinsUSPTOApplication 17448033
Show all 39 patent records
- Lysates Of Recombinant Yeast For Inducing Cellular Immune ResponsesJan 9, 2025 · Application 18897645Pending
- Lysates Of Recombinant Yeast For Inducing Cellular Immune ResponsesOct 29, 2024 · US 12,128,078Granted
- Anti COVID-19 Therapies Using Nucleocapsid And Spike ProteinsJan 27, 2022 · Application 17448033Pending
- Methods And Compositions For Modulating Myeloid-derived Suppressor CellsSep 23, 2021 · Application 17264624Pending
- Compositions And Methods For The Treatment Or Prevention Of Human Immunodeficiency Virus InfectionDec 1, 2020 · US 10,849,971Granted
- Mass-Spectral Method for Selection, and De-selection, of Cancer Patients for Treatment with Immune Response Generating TherapiesMar 17, 2020 · US 10,593,529Granted
- Compositions and Methods for the Treatment or Prevention of Hepatitis B Virus InfectionOct 15, 2019 · US 10,441,650Granted
- Compositions And Methods For The Treatment Or Prevention Of Human Immunodeficiency Virus InfectionApr 23, 2019 · US 10,265,393Granted
- Yeast-based Compositions And Methods For The Treatment Or Prevention Of Hepatitis Delta Virus InfectionJun 5, 2018 · US 9,987,352Granted
- Compositions and Methods for the Treatment or Prevention of Hepatitis B Virus InfectionApr 17, 2018 · US 9,943,591Granted
- Compositions And Methods For The Treatment Or Prevention Of Human Immunodeficiency Virus InfectionOct 10, 2017 · US 9,782,473Granted
- Methods For Producing Yeast-based VaccinesJan 24, 2017 · US 9,549,970Granted
- Compositions and Methods to Elicit Immune Responses Against Pathogenic Organisms Using Yeast-Based VaccinesMay 10, 2016 · US 9,333,246Granted
- Yeast-based Therapeutic For Chronic Hepatitis B InfectionMar 22, 2016 · US 9,290,547Granted
- Yeast-based Therapeutic For Chronic Hepatitis C InfectionSep 2, 2014 · US 8,821,892Granted
- Compositions And Methods For The Treatment Or Prevention Of Hepatitis B Virus InfectionMay 13, 2014 · US 8,722,054Granted
- Ras Mutation and Compositions and Methods Related TheretoDec 26, 2013 · Application 13799496Pending
- Improved Methods For Producing Yeast-based VaccinesApplication PCTUS2008052843Pending
- Compositions And Methods For Targeted Ablation Of Mutational Escape Of Targeted Therapies For CancerApplication PCTUS2008051348Pending
- Ras Mutation And Compositions And Methods Related TheretoApplication PCTUS2007063711Pending
- Yeast-based Vaccine For Inducing An Immune ResponseApplication PCTUS2007061572Pending
- Compositions And Methods For Eliciting An Immune Response To Escape Mutants Of Targeted TherapiesApplication PCTUS2006026710Pending
- Yeast-based Therapeutic For Chronic Hepatitis C InfectionApplication PCTUS2005037499Pending
- Anti COVID-19 Therapies using nucleocapsid and spike proteinsApplication 63117922Pending
- Methods And Compositions For Modulating Myeloid-derived Suppressor CellsApplication PCTUS2019051747Pending
- Lysates Of Recombinant Yeast For Inducing Cellular Immune ResponsesApplication PCTUS2019031962Pending
- Methods And Compositions For Modulating Myeloid-derived Suppressor CellsApplication 62734350Pending
- Lysates of Recombinant Yeast for Inducing Cellular Immune ResponsesApplication 62671587Pending
- Yeast-based Immunotherapy Ad Type 1 Interferon SensitivityApplication PCTUS2015025316Pending
- Ras G12R Immunotherapy For Ras Mutation-positive CancersApplication PCTUS2015015840Pending
- Compositions And Methods For The Treatment Or Prevention Of Human Immunodeficiency Virus InfectionApplication PCTUS2014031811Pending
- Yeast-Based Immunotherapy for ChordomaApplication 61803332Pending
- Compositions And Methods For The Treatment Or Prevention Of Hepatitis Delta Virus InfectionApplication PCTUS2012042426Pending
- Compositions And Methods For The Treatment Or Prevention Of Hepatitis B Virus InfectionApplication PCTUS2012024409Pending
- Compositions And Methods For The Treatment Or Prevention Of Human ADENOVIRUS-36 InfectionApplication PCTUS2011065868Pending
- Pharmacogenomic And Response-guided Treatment Of Infectious Disease Using Yeast-based ImmunotherapyApplication PCTUS2011028359Pending
- Combination Immunotherapy Compositions And MethodsApplication PCTUS2010031460Pending
- Genotyping Tools, Methods And KitsApplication PCTUS2009066393Pending
- Immunotherapy For Chronic Hepatitis C Virus InfectionApplication PCTUS2009057535Pending
Related companies, and why
- Akero TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Pionyr ImmunotherapeuticsSimilar federal contract value in Biotech · null in contracts
- Nkarta, Inc.Similar federal contract value in Biotech · null in contracts
- Liquid BioScience, Inc.Similar federal contract value in Biotech · null in contracts
- Earli Inc.Similar federal contract value in Biotech · null in contracts
- Bugworks Research, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .